Stock listing
NASDAQ:SGTX Sigilon Therapeutics Inc Stock
Follow Sigilon Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:SGTX
$22.47 USD
Close on Aug 11, 2023 · No longer trades
- Lowest – highest close
- $3.91 – $23.06 USDSince May 23, 2023 · lowest Jun 23, 2023 · highest Aug 9, 2023
Delisted NASDAQ:SGTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SGTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Sigilon Therapeutics Inc on 6ix
- Decks
- 6 decks · latest Mar 14, 2023
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2023) | Investor deck | 24 slides | Mar 14, 2023 |
| Corporate Update (November 2022) | Corporate update | 29 slides | Nov 10, 2022 |
| Investor Presentation (October 2022) | Investor deck | 21 slides | Oct 11, 2022 |
| Investor Presentation (March 2022) | Investor deck | 28 slides | Mar 14, 2022 |
| Q2 2021 Earnings Presentation | Earnings | 30 slides | Aug 10, 2021 |
| Corporate Update (May 2021) | Corporate update | 21 slides | May 10, 2021 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Douglas G Cole Other companies: Foghorn Therapeutics Inc. (Director · Since at least Oct 22, 2020); Sana Biotechnology, Inc. (Director · Feb 3, 2021 – Jun 6, 2024 · Past); Denali Therapeutics Inc. (Director · Dec 7, 2017 – Jun 1, 2023 · Past); Quanterix Corporation (Director · Dec 6, 2017 – Jan 2, 2019 · Past); Editas Medicine, Inc. (Director · Feb 2, 2016 – Aug 17, 2017 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Aug 10, 2016 · Past); Receptos Inc (Director · May 8, 2013 – Jul 17, 2013 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Mar 25, 2013 · Past); AVEO Pharmaceuticals Inc (Director · Mar 11, 2010 – May 12, 2011 · Past) | Director · Dec 3, 2020 – Aug 11, 2023 · Past |
| Coelho Rogerio Vivaldi Other companies: Viatris Inc. (Director · Since at least Jun 3, 2024); Crinetics Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2022); Bioverativ Inc (EVP, Chief Global Therapeutics · Dec 22, 2016 – Mar 8, 2018 · Past); Spark Therapeutics Inc (Chief Commercial Officer · Jan 29, 2015 – Jul 15, 2016 · Past); Minerva Neurosciences, Inc (President and CEO, Director · Jun 30, 2014 – Jun 30, 2014 · Past) | PRESIDENT AND CEO, Director · Dec 3, 2020 – Aug 11, 2023 · Past |
| John Cox Other companies: Dyne Therapeutics, Inc. (President and Chief Executive Officer · Since at least Mar 25, 2024); Bioverativ Inc (Chief Executive Officer, Director · Dec 22, 2016 – Mar 8, 2018 · Past); Repligen Corporation (Director · Nov 15, 2013 – Mar 24, 2020 · Past); Biogen Inc. (EVP Pharmaceutical Oper & Tech · Nov 1, 2011 – Apr 1, 2016 · Past) | Director · Dec 3, 2020 – Aug 11, 2023 · Past |
| Kavita Patel Other companies: Arcellx Inc (Director · Since at least Feb 3, 2022); SelectQuote, Inc. (Director · Since at least Sep 23, 2020); Intelligent Medicine Acquisition Corp (Director · Nov 4, 2021 – Nov 4, 2021 · Past) | Director · Dec 3, 2020 – Aug 11, 2023 · Past |
| Brooke Story Other companies: PolyPid Ltd. (Chairman of the Board · Since at least Dec 16, 2025); LivaNova PLC (Director since 2022 · Since at least Sep 15, 2022) | Director · Jun 14, 2021 – May 26, 2022 · Past |
| Glenn Reicin Other companies: Harmony Biosciences Holdings, Inc. (Chief Financial Officer · Since at least Apr 14, 2026); Jasper Therapeutics, Inc. (Director · Nov 19, 2019 – Nov 19, 2019 · Past) | CHIEF FINANCIAL OFFICER · Dec 3, 2020 – Feb 11, 2021 · Past |
| Matthew P. Kowalsky Other companies: Enanta Pharmaceuticals, Inc. (Chief Legal Officer · Since at least Apr 29, 2024); Protara Therapeutics, Inc. (VP, Legal and Secretary · Apr 27, 2017 – Jan 18, 2019 · Past) | CHIEF OF STAFF AND CLO · Feb 28, 2023 – Aug 11, 2023 · Past |
| Daniel Griffith Anderson | Director · Dec 3, 2020 – Jun 2, 2021 · Past |
| Josias Pontes | CHIEF FINANCIAL OFFICER · Jun 14, 2021 – Aug 11, 2023 · Past |
Log in to ask 6ix AI your own questions about Sigilon Therapeutics Inc.